Statins as an adjuvant therapy for patients with schizophrenia: An up-to-date systematic review and meta-analysis
- 7 May 2024
- journal article
- review article
- Published by Elsevier in General Hospital Psychiatry
- Vol. 89, 75-83
Abstract
No abstract availableKeywords
Funding Information
- Taipei City Hospital (NTPC 113\u2013001)
This publication has 32 references indexed in Scilit:
- Statin use and depression risk: A systematic review and meta-analysisJournal of Affective Disorders, 2021
- Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implicationsPsychiatry Research, 2018
- Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysisPsychiatry Research, 2018
- Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trialPsychiatry Research, 2014
- Converting positive and negative symptom scores between PANSS and SAPS/SANSSchizophrenia Research, 2014
- Pleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends in Molecular Medicine, 2008
- Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injuryLife Sciences, 2007
- What does the PANSS mean?Schizophrenia Research, 2005
- Size of burden of schizophrenia and psychotic disordersEuropean Neuropsychopharmacology, 2005
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986